The DOI matches its Crossref record; 81 of the 84 references it cites were found in a registry or an index; 20 of the 60 sources its claims cite were checked for support.
Risk Factors for Self-Harm Ideation Among Persons Treated With Opioids for Chronic Low Back Pain
Open accessAbstract
Objectives: Chronic pain is a significant health concern that adversely affects all aspects of life, including emotional well-being. Opioids are prescribed for the management of refractory, severe chronic pain, although they have been associated with adverse effects, including addiction and overdose. The aim of this study was to examine factors that predict thoughts of self-harm among adults with chronic pain who are prescribed opioids. Materials and Methods: Seven hundred sixty-five (N=765) persons with opioid-treated chronic lower back pain completed the Current Opioid Misuse Measure (COMM) and other validated questionnaires as part of a larger study. Response to 1 question from the COMM ("How often have you seriously thought about hurting yourself?") was used to assess suicide risk on a 5-point scale (0=never; 4=very often). Results: Participants were categorized into 3 groups according to their responses to the self-harm question: never (N=628; 82.1%), seldom or sometimes (N=74; 9.7%), and often or very often (N=63; 8.2%). Multivariate adjusted odds ratio (aOR) analyses indicated that reports of alcohol or drug overuse within the past month (aOR=1.41,[95% CI 1.11-1.78]), posttraumatic stress (PTSD; aOR=1.24,[1.07 to 1.44]), pain catastrophizing (aOR=1.03,[1.01 to 1.05]), not loving oneself (aOR=0.99,[.98-1.00]) and poor perceived mental health (aOR=0.94,[.92 to 97]) were most associated with thoughts of self-harm. Importantly, the ideation frequency of self-harm was highest among individuals treated with higher daily doses of opioids. Discussion: These results support the need for continued monitoring of adults treated with opioids for chronic pain, particularly among those on high-dose opioids who present with increased negative affect and concerns of substance misuse. © 2023 Lippincott Williams and Wilkins. All rights reserved.
Overview
CoChat Summary
TL;DR
In baseline data from 765 adults with opioid-treated chronic low back pain, 17.9% reported any thoughts of self-harm, including 8.2% who reported “Often or Very Often.” Alcohol/drug overuse, PTSD symptoms, pain catastrophizing, lower self-love, and poorer mental health quality of life were associated with self-harm ideation, while opioid dose alone was not predictive in the final model.
Key findings
- Among 765 participants, 628 (82.1%) reported “Never,” 74 (9.7%) reported “Seldom or Sometimes,” and 63 (8.2%) reported “Often or Very Often” thoughts of self-harm on the COMM item.
- In adjusted odds ratio analyses, the strongest predictor was past-month alcohol or drug overuse (aOR=1.41, 95% CI 1.11–1.78; table OR=1.405), followed by PTSD symptoms (aOR=1.24, 95% CI 1.07–1.44), pain catastrophizing (aOR=1.03, 95% CI 1.01–1.05), not loving oneself (aOR=0.99, 95% CI .98–1.00), and poor perceived mental health (aOR=0.94, 95% CI .92–.97).
- The highest self-harm ideation group reported higher mean morphine-equivalent daily dose (186.1 mg/day vs. 174.1 mg/day in the “Never” group), but no between-group differences in MEDD were found, and opioid dose did not enter the final regression model.
- Group differences were also found for greater pain interference, back pain-related disability, PTSD symptoms, negative affect, pain catastrophizing, neuropathic pain, loneliness, feeling unloved, and mental health care visits; no differences were found for average pain severity, pain acceptance, or cigarette smoking.
Methods
- Cross-sectional baseline analysis of 765 adults with chronic low back pain from a larger multicenter randomized controlled trial (NCT03115359); inclusion required age ≥21, average pain ≥3/10, Oswestry Disability Index >20, and ≥15 mg/day morphine-equivalent opioids for the past 3 months, recruited from Boston, Madison, and Salt Lake City.
- Measures included the Current Opioid Misuse Measure (COMM) self-harm item (“How often have you seriously thought about hurting yourself?” rated 0=Never to 4=Very Often), plus validated questionnaires for pain, function, quality of life, PTSD, catastrophizing, negative affect, mindfulness, pain acceptance, loneliness, feeling loved, and opioid dose via Timeline Followback.
- Responses were collapsed into three groups (“Never,” “Seldom/Sometimes,” “Often/Very Often”); analyses used ordinal subset stepwise regression with adjusted odds ratios, multiple imputation for missing data, and False Discovery Rate adjustment for multiple comparisons.
Limitations
- The paper states this was a cross-sectional baseline study, so no causal relationship can be determined; all participants were prescribed opioids, so comparisons were not made with non-opioid users; data were mostly self-report; participants were not directly asked about suicide, and no information was obtained about actual opioid misuse.
- The paper notes possible chance findings due to many variables, mitigated with FDR; selection bias is possible, and the sample was mostly White, female, and post-high-school educated, limiting generalizability; thoughts of self-harm do not always translate into a suicide plan, and under-reporting of medication misuse, distress, and self-harm thoughts is possible.
- Evident from the text: self-harm risk was assessed with a single COMM item rather than a dedicated suicide-risk instrument, and the baseline RCT sample may not represent all clinical populations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
6 Valid · 12 Not valid · 20 Not checked · 54 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“During the follow-up period of almost 2-years, the studies showed a significantly higher incidence of suicide and overdose death within the first three months among those tapering off opioids compared with those who were newly started and who continued taking prescription opioids.”
What the sources say
- Not checked — no full text of the sourcecites [62] Stone DM, Jones CM, Mack KS. Changes in Suicide Rates — United States, 2018–2019. Office of Mental Health and Suicide Prevention Statistics. 2021;70;261–268. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Disputedcites [63] Oliva EM, Bowe T, Manhapra A, Kertesz S et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020. ;368:m283. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Of 770 adults with opioid-treated CLBP who enrolled in the larger RCT, 765 completed the Current Opioid Misuse Measure (COMM) at baseline27 and were included in the analysis.”
What the sources say
- Partly supportedcites [27] Zgierska AE, Burzinski CA, Garland E, Lennon RP, Jamison RN, Nakamura Y, Barrett B, Sehgal N, Mirgain SA, Singles JM, Cowan P, Woods D, Edwards RR. Mindfulness-based therapy compared to cognitive behavioral therapy for opioid-treated chronic low back pain: protocol for a pragmatic randomized controlled trial. Contemp Clin Trials. 2021. Nov;110:106548. PMID: 34478870. [DOI] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
Section 2.10.3 identifies COMM as a measure in this trial, and section 2.10 says participants complete a baseline assessment. The protocol does not report that 770 enrolled or that 765 completed COMM at baseline; it reports a sample-size goal of 766 in the “12-month exit visit” section. Page numbers are unavailable in our copy. (LLM, conf=0.86)
plainn = 765- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“risk of suicide has been shown to be greater among individuals treated with higher-dose opioids.57”
What the sources say
- Could not verifycites [57] Ilgen MA, Bohnert ASB, Ganoczy D, Bair MJ, McCarthy JF, Blow FC. Opioid dose and risk of suicide. Pain. 2016. ; 157:1079–1084. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Results (Patient Demographic Characteristics and Patient Engagement Results; pages not provided) report whether participants took opioids, but not opioid dose or suicide risk. Searches of our copy for suicide and higher-dose opioids found no passage addressing the claimed association. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“In large retrospective studies conducted through the Office of Mental Health and Suicide Prevention and the Department of Veterans Affairs,62, 63 incidence of overdose or suicide death among individuals who were started compared with those who discontinued opioid therapy was documented.”
What the sources say
- Not checked — no full text of the sourcecites [62] Stone DM, Jones CM, Mack KS. Changes in Suicide Rates — United States, 2018–2019. Office of Mental Health and Suicide Prevention Statistics. 2021;70;261–268. [DOI] [PMC free article] [PubMed] [Google Scholar] source
- Could not verifycites [63] Oliva EM, Bowe T, Manhapra A, Kertesz S et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020. ;368:m283. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Having post-traumatic stress symptoms (aOR=1.24), higher pain catastrophizing (aOR=1.03), not loving oneself (aOR=0.99), and perceived lower mental quality of life (aOR=0.94), were also most predictive of thoughts of self-harm and suicide risk.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
34 more claims
Create a free account to see all 92 claims and every source verdict.
- Probably not a substantial claim. 38
- It may state two separate claims as one. 23
- Not yet classified. 8
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“SF12_Mental 0.941 0.904 0.978”
Reported 0.941 · recomputed 0.74569
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Every 5-point increase in the scale Odds Ratio Lower Upper FLI: Love_Self 0.744 0.655 0.845”
Reported 0.744 · recomputed 0.941423
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Injections (e.g., epidural steroid, facet) YES 614 (81.7) 494 (80.3) 110 (89.4) 10 (71.4)”
Reported 89.4 · recomputed 148.648649
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Positive screen (score 9+), n (%) 349 (45.6) 235 (37.4%) 101 (82.1) 13 (92.8)”
Reported 82.1 · recomputed 136.486486
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“53 In assessing possible explanations of thoughts of self-harm, we employed ordinal subset stepwise regression modeling based on those variables found to show signi fi cant differences among the self-harm ideation frequency groups.”
MethodThe Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
The benefits of being present: Mindfulness and its role in psychological well-being
Brown, K. W., & Ryan, R. M. (2003) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.84.4.822 · Cited by 13,448
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · cited 1×
“34,35 38 This is a valid and reliable 13-item instrument that examines components of catastrophizing (rumination, magni fi cation, and helplessness) associated with chronic pain; (8) Pain Detect Neuropathic Pain Questionnaire.”
BackgroundThe Pain Catastrophizing Scale: Development and validation.
Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995) · Psychological Assessment · doi:10.1037//1040-3590.7.4.524 · Cited by 8,227
Pain assessment: global use of the Brief Pain Inventory.
Cs, C., & Km, R. (1994) · PubMed · Cited by 5,421
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
A Short Scale for Measuring Loneliness in Large Surveys: Results From Two Population-Based Studies
Hughes, M. E., Waite, L. J., Hawkley, L. C., & Cacioppo, J. T. (2004) · Research on Aging · doi:10.1177/0164027504268574 · Cited by 4,781
Cited by
A randomized trial of collaborative support for opioid taper after trauma hospitalization
Sullivan, M. D., Katers, L. A., Wang, J., Arbabi, S., Tauben, D. J., & Baldwin, L. (2024) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-024-00613-x · Cited by 3
“There is also little evidence of the efficacy of long-term opioid therapy and growing evidence of harm, including impaired endogenous pain modulation and increased risk of self-harm [4, 5].”
BackgroundDolor crónico y conducta suicida. Una revisión narrativa de la literatura
Barrios, V., Kaplan, M. I., Prats, A., Perez, S. A. G., Miracco, M., & Albajes, K. (2025) · Multidisciplinary Pain Journal · doi:10.20986/mpj.2025.1083/2024
D'Etienne, J., Abduganiev, S., Warrior, R., & Wang, H. (2025) · Healthcare · doi:10.3390/healthcare13212674
“Previous research indicates that a significant number of individuals who misuse pain relievers suffer from severe psychogenic disorders (SPDs) with a higher prevalence of suicide [8–10].”
Suicide and Chronic Pain: Scoping Review with ☸️SAIMSARA
SAIMSARA (2026) · SAIMSARA Journal · doi:10.62487/saimsara5e0bf3a7
Cheatle, M. D., Lee, Y.-J., Zhu, J., Kass, G., & Rizvi, S. J. (2026) · Journal of Pain · doi:10.1016/j.jpain.2026.106445
Metadata
- Authors
- Jamison, R. N., Edwards, R. R., Brown, R., Barrett, B. P., Burzinski, C. A., Lennon, R. P., Nakamura, Y., Schiefelbein, T., Garland, E. L., & Zgierska, A. E.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Wisconsin–Madison (US)
- Pennsylvania State University (US)
- University of Utah (US)
- Corresponding author
- Jamison, Robert N.
- Edwards, Robert R.
- ORCID
- Venue
- The Clinical Journal of Pain
- Published
- 2023-09-15
- Volume
- 39
- Issue
- 12
- Pages
- 643-653
- ISSN
- 0749-8047 (ISSN-L)
- 1536-5409
- PMC
- PMC10695275
- OpenAlex
- W4386757691
- Cited by
- 6
- References
- 84
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 2
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of Pain (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Brigham and Women's Hospital
- Patient-Centered Outcomes Research Institute (OPD-1601-33860)
- University of Wisconsin-Madison
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- self-harm ideation, suicide risk, chronic low back pain, opioid therapy, chronic pain, substance abuse, post-traumatic stress, pain catastrophizing, self-compassion, perceived mental health, opioid dose
- MeSH terms
- Adult, Analgesics, Opioid, Humans, Opioid-Related Disorders, Risk Factors, Self-Injurious Behavior, Low Back Pain, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk Factors for Self-Harm Ideation Among Persons Treated With Opioids for Chronic Low Back Pain. https://app.cochat.ai/papers/10.1097/ajp.0000000000001161
- The paper
- Jamison, R. N., Edwards, R. R., Brown, R., Barrett, B. P., Burzinski, C. A., Lennon, R. P., Nakamura, Y., Schiefelbein, T., Garland, E. L., & Zgierska, A. E. (2023). Risk Factors for Self-Harm Ideation Among Persons Treated With Opioids for Chronic Low Back Pain. The Clinical Journal of Pain. https://doi.org/10.1097/ajp.0000000000001161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.